Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Mesothelial

Explore clinical trials studying Neoplasms, Mesothelial. Study availability and eligibility vary by location and protocol.

370 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Mesothelial trial results

Active, Not Recruiting

Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin

NCT02535312

Conditions
Adenoma, Advanced Malignant Solid Neoplasm, Advanced Peritoneal Malignant Mesothelioma, +18 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma

NCT03126630

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 33 locations
View Trial Details
Active, Not Recruiting

A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma

NCT04897022

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited protocol activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)

NCT06155279

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • Humanitas Gavazzeni Bergamo, Italia/Bergamo, Italy
  • IFO - Istituto Tumori Regina Elena, Roma Roma, Italia/Roma, Italy
  • Istituto Clinico Humanitas Rozzano, Milano, Italy
  • Centro di Riferimento Oncologico (CRO) IRCCS Aviano, Pordenone, Italy
View Trial Details
Active, Not Recruiting

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

NCT05544929

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenoma, +83 more
Locations
  • Massachusetts General Hospital . Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • NYU School of Medicine New York, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
Locations
  • Shalby Hospital Ahmedabad, Gujarat, India
  • National Cancer Institute Jhajjar, Haryana, India
  • All India Institute of Medical Sciences New Delhi, India
  • PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India
View Trial Details

Related conditions